Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-02

Clinical Trial Update: Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression [Phase 4]

View source ↗

Summary

Phase 4 study results evaluating memantine added to lamotrigine for bipolar depression with incomplete response were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)
  • Memantine (memantine)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Bipolar Depression | Phase 4 | Status: COMPLETED | Results posted: 2015-11-02